Americord Registry
Americord Registry is a privately held U.S. direct-to-consumer biobanking company founded in 2008 that cryogenically preserves newborn cord blood, cord tissue, placental tissue, and exosomes for individual families across all 50 states.
- Company typePrivate
- Founded2008
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Americord Registry does
Americord Registry is a privately held U.S. direct-to-consumer biobanking company founded in 2008 by Martin Smithmyer and headquartered in Somerset, New Jersey. The company cryogenically preserves umbilical cord blood, cord tissue, placental tissue, and exosomes collected at birth for individual families across all 50 states, positioning these samples as a form of biological insurance for the child and first- and second-degree relatives against 80+ FDA-approved treatments and over 300 active clinical trials.
The company's technical differentiation rests on proprietary wet-lab methods rather than software: the trademarked CryoMaxx™ processing and Cord Blood 2.0® collection methods (developed by Medical Director Dr. Robert Dracker) are claimed to yield materially more stem cells than industry-average processes, and an industry-first 5-compartment storage bag allows multiple future treatments from a single collection. Operations are anchored by an AABB-accredited, FDA-registered, AATB-compliant, CLIA-certified in-house laboratory, with strategic partnerships with GenVault (disaster recovery), Tutela (remote temperature monitoring), and Veritas Genetics / LetsGetChecked (genomic screening). The 2023 relocation of the lab from New York City to Somerset, NJ consolidated processing, R&D, and storage in a single upgraded facility.
Commercially, Americord operates a DTC enrollment model via americordblood.com and phone sales with in-house stem cell consultants, complemented by OB/GYN referrals, seasonal promotions, a referral/ambassador program, and celebrity endorsements. Revenue comes from one-time processing and enrollment fees ($1,078 Essential up to $5,979+ Maximum plans) bundled with recurring annual storage fees, with an AmeriFlex 12% APR monthly payment plan lowering the upfront barrier. The customer base is a long tail of expecting-parent households; named clients include the Steve Barney family (Duke University childhood apraxia treatment), the Eli Cola-Achille family (Dana-Farber sickle cell treatment), and celebrities Scheana Shay and Whitney Port, alongside a growing portfolio that now includes maternal exosome banking, genomic screening, and the Lizia pregnancy tracking iOS app.
Americord Registry firmographics
Firmographics- Name
- Americord Registry
- Legal name
- Americord Registry LLC
- Website
- https://americordblood.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Americord Registry is a privately held U.S. direct-to-consumer biobanking company founded in 2008 that cryogenically preserves newborn cord blood, cord tissue, placental tissue, and exosomes for individual families across all 50 states.
- Ownership category
- akta.pro rank
Americord Registry industry classification
Industry- Product category
- Stem Cell Banking / Biobanking Services
- NAICS
- Blood and Organ Banks (621991), Medical and Diagnostic Laboratories (6215), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)
- akta.pro secondary industries
- Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats) (HLAGAIAJ), Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI), Newborn Screening & Genetic Public Health Laboratories (HLAJAIAJ)
Keywords
Where Americord Registry is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Americord Registry business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Operations, Personnel, Marketing or Sales, Technology or R&D, Supply Chain, Infrastructure
Revenue model
- Cord Blood Banking: Private cord blood stem cell banking for families. Parents pay upfront for collection, processing, and storage over a defined or lifetime period. Core recurring revenue from annual storage fees and one-time fees for processing. Plans range from Essential (cord blood only) to Maximum (cord blood + tissue + exosomes).
- Cord Tissue Banking: Preservation of umbilical cord tissue containing mesenchymal stem cells (MSCs) for future regenerative medicine applications. Offered as standalone service or bundled in higher-tier family plans.
- Placental Tissue Banking: Banking of placental tissue using proprietary CryoMaxx processing to preserve amnion and chorion layers with multipotent cells, growth factors, and cytokines. Can be bundled with cord blood and cord tissue services.
- Exosome Banking: Banking of exosomes from cord blood plasma or maternal exosomes for future clinical trial participation and regenerative medicine applications. Newer service expanding beyond newborn biobanking into maternal health.
- AmeriFlex Payment Plans: Financing option allowing monthly payments over the storage period at 12% APR with no credit check. Also offers 12-month and 24-month installment plans. Provides extended payment flexibility to lower upfront cost barriers for families.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Essential Family Plan — Cord Blood Banking only |
| One time/ perpetual license | Multi-year contract | Advanced Family Plan — Cord Blood + Cord Tissue Banking |
| One time/ perpetual license | Multi-year contract | Complete Family Plan — Cord Blood + Cord Tissue + Placental Tissue Banking |
| One time/ perpetual license | Multi-year contract | Ultimate Family Plan — Cord Blood + Cord Tissue + Placental Tissue + Newborn Exosome Banking |
| One time/ perpetual license | Multi-year contract | Maximum Family Plan — All services including Maternal Exosome Banking |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels9 records
Americord Registry product offering
Product offeringCore offering
Americord Registry collects, processes, and cryogenically stores newborn stem cells from umbilical cord blood, umbilical cord tissue, placental tissue, and exosomes for expecting families across all 50 U.S. states. Parents enroll before birth, receive a proprietary 4-in-1 collection kit, and the samples are transported to Americord's AABB-accredited in-house laboratory in Somerset, New Jersey for processing using CryoMaxx and storage in a 5-compartment bag at -196°C for potential use in 80+ FDA-approved treatments and 300+ clinical trials. The company sells this through tiered Family Plan packages (Essential, Advanced, Complete, Ultimate, Maximum) with one-time processing fees plus recurring annual, multi-year, or lifetime storage fees.
Product overview
Americord Registry operates as a newborn stem cell banking company offering a comprehensive portfolio of biobanking services. The core offering consists of four primary banking services—Cord Blood Banking, Cord Tissue Banking, Placental Tissue Banking, and Exosome Banking—all processed using the company's proprietary CryoMaxx™ Processing technology. These services are delivered through tiered Family Plan packages (Essential through Maximum) and supported by proprietary collection and storage technologies including the 4-in-1 Collection Kit and industry-first 5-Compartment Storage Bag. The company also offers the Lizia pregnancy tracking mobile app, AmeriRush expedited shipping, and flexible payment options through AmeriFlex. All services are backed by an industry-leading $110,000 engraftment guarantee and supported by an in-house AABB-accredited laboratory in Somerset, New Jersey.
Differentiator
Problem solved
Functional benefit
Products and services
- Cord Blood Banking Cryogenic preservation of umbilical cord blood stem cells for potential use in 80+ FDA-approved treatments and hundreds of clinical trials, available to expecting parents across all 50 U.S. states.
- Cord Tissue Banking Preservation of umbilical cord tissue containing mesenchymal stem cells (MSCs) for potential use in clinical trials to treat the baby and family members, available as a standalone service or bundled in higher-tier family plans.
- Placental Tissue Banking Preservation of placental tissue containing amniotic epithelial cells, mesenchymal stem cells, growth factors, and cytokines for wound healing, tissue repair, and various therapeutic applications.
- Exosome Banking Preservation of powerful exosomes from cord blood plasma (newborn) or maternal blood that can stimulate healing in the body, representing the scientific frontier in regenerative medicine and clinical trial participation.
- AmeriRush Shipping Expedited shipping add-on service that delivers the collection kit within 24-48 hours for clients with due dates within 2 days. Required for imminent due dates; available for $189 in addition to standard shipping.
- Lizia Pregnancy App Free, 100% private, ad-free pregnancy tracking mobile application for iOS devices featuring milestone tracking, contraction timing, and community support. Functions as a customer acquisition and brand engagement touchpoint.
Quantifiable outcome
- 60% more CD34+ stem cells, 54% more cord blood, and 34% higher TNC compared to competitors
- +5 more outcomes
Companies that use Americord Registry
Customer profileNamed customers8 records
Segments3 records
Ideal customer profiles1 record
Americord Registry technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Americord Registry partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- GenVaultcoreStrategic partnership with GenVault for disaster recovery and emergency preparedness. Through this partnership, Americord ensures the immediate extraction and secure transfer of all cryogenic storage tanks to a secondary location in the event of a facility-wide threat, protecting biological assets from natural disasters or other emergencies.
- TutelacoreThird-party remote environmental monitoring service. Tutela's temperature sensors and ultra-low freezer probes report data to a monitored interface, providing remote alerts to key Americorp employees if temperatures deviate from the calibrated range in cryogenic storage tanks.
Scale indicators7 records
Recent moves7 records
Expansion highlights5 records
Americord Registry competitors and assessment
Company assessmentDirect peers
- Cord Blood Registry (CBR): Cord Blood Registry is one of the largest private cord blood banks in the U.S. with similar services (cord blood and tissue banking, family plans) and a comparable direct-to-consumer go-to-market model targeting expectant parents.
- StemCyte: StemCyte operates both a public cord blood bank and private family banking services, offering similar cryopreservation of cord blood and perinatal tissue with comparable regulatory credentials.
- New England Cord Blood Bank: New England Cord Blood Bank is a hybrid public/private cord blood bank offering family banking services with similar AABB accreditation and direct-to-consumer positioning.
- Carolinas Cord Blood Bank: Carolinas Cord Blood Bank provides both public donation and private family storage of cord blood, competing in the same direct-to-consumer market segment with similar regulatory profile.
- ViaCord: ViaCord, a Revvity/PerkinElmer company, provides cord blood and cord tissue banking with comparable regulatory accreditations, family storage plans, and a direct-to-consumer sales motion targeting expecting families.
- LifebankUSA: LifebankUSA (a subsidiary of CBR/Generate Life Sciences) offers cord blood banking along with placenta and tissue banking, mirroring Americord's service breadth and family-plan packaging.
- Cryo-Cell International: Cryo-Cell International is a publicly traded cord blood banking company offering umbilical cord blood and cord tissue cryopreservation services with similar product positioning and target customer (expectant parents).
- AlphaCord: AlphaCord is a private cord blood and tissue bank offering similar service tiers and family banking plans with comparable direct-to-consumer sales motion targeting expectant parents.
Emerging players
- Veritas Genetics (LetsGetChecked): Veritas Genetics, now part of LetsGetChecked, offers whole-genome and newborn genetic screening that overlaps with Americord's genomic partnership offering. Comparable through the prenatal genetic testing category rather than direct storage competition.
Broad incumbents
- Generate Life Sciences: Generate Life Sciences is the parent of Cord Blood Registry and other reproductive services, operating as a broader incumbent across cord blood banking, fertility, and newborn screening with significantly greater scale and capital backing than Americord.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Americord Registry social profiles
Digital presenceAmericord Registry compliance and trust
Trust signalCompliance6 records
Americord Registry financial estimates
Financial estimateRevenue estimate
Valuation estimate
Americord Registry leadership team
Management profileNumber of profiles
Profiles8 records
Americord Registry funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Americord Registry M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Americord Registry
What does Americord Registry do?
Americord Registry collects, processes, and cryogenically stores newborn stem cells from umbilical cord blood, umbilical cord tissue, placental tissue, and exosomes for expecting families across all 50 U.S. states. Parents enroll before birth, receive a proprietary 4-in-1 collection kit, and the samples are transported to Americord's AABB-accredited in-house laboratory in Somerset, New Jersey for processing using CryoMaxx and storage in a 5-compartment bag at -196°C for potential use in 80+ FDA-approved treatments and 300+ clinical trials. The company sells this through tiered Family Plan packages (Essential, Advanced, Complete, Ultimate, Maximum) with one-time processing fees plus recurring annual, multi-year, or lifetime storage fees.
Is Americord Registry a public or private company?
Americord Registry is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Americord Registry founded?
Americord Registry was founded in 2008. It employs 11 to 50 people.
Where is Americord Registry based?
Americord Registry is headquartered in New York, United States, in the North America region.
How does Americord Registry make money?
Five revenue lines are on record. Cord Blood Banking is the primary driver. The others are cord Tissue Banking, placental Tissue Banking, exosome Banking and ameriFlex Payment Plans.
Who are Americord Registry's main competitors?
Direct peers on record are Cord Blood Registry (CBR), StemCyte, New England Cord Blood Bank, Carolinas Cord Blood Bank, ViaCord, LifebankUSA, Cryo-Cell International and AlphaCord. Veritas Genetics (LetsGetChecked) is listed as an emerging player. Generate Life Sciences is listed as a broad incumbent.
Does Americord Registry have an API?
No public API is recorded for Americord Registry.
What industry is Americord Registry in?
Americord Registry's product category is Stem Cell Banking / Biobanking Services. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue), with a secondary code of HLAGAIAJ, Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats). Its NAICS code is 621991 and its SIC code is 2836.